Ngm Biopharmaceuticals competitive analysis

Loading summary...

Explore patent oppositions filed by Ngm Biopharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Klotho-Beta For Use In Treating Cancer, Liver Disorders, Gallstones, Wasting Syndrome And Obesity-Related DiseasesGENENTECHNov 20, 2018

Latest publications and patents of Ngm Biopharmaceuticals New

Explore the latest publications and patents granted to Ngm Biopharmaceuticals, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Ngm Biopharmaceuticals

Discover the latest PTAB cases involving Ngm Biopharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ngm Biopharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NGM BIOPHARMACEUTICALS1 - - -
GENENTECH - 87 - 65